The real AI opportunity in clinical trials isn’t efficiency – it’s simulating better studies before enrollment begins.
- Why Are Life Science Companies So Poorly Prepared For RIM's Future?
- Digital Endpoints Are Ready. Clinical Development Isn't
- Why Clinical Trial Data Cleaning Must Go Continuous (And How To Do It)
- What Clinical Analytics Solutions Are Shaping Clinical Research
- Sites Are Building Their Own Tech – SCRS On What That Means
- Human-In-The-Loop In AI Validation And Control: From Principle To Practice
- When The System Breaks, Who Pays? SCRS On Site Tech Gaps
- HTA, Digital Twins, And Building Clinical Tech That Lasts
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Suvoda Products
Suvoda Products Listing.
-
Medable Platform Delivers >90% eCOA Adherence And Scalability
Discover how eCOA use drove >90% adherence across an extensive weight management master protocol clinical trial with multiple sub-studies across 70+ research sites.
-
How Can Real-World Data Benefit Your Trials?
Clinical trial data is being supplemented with real-world data (RWD) gathered from a variety of sources. Dive deeper into this emerging trend to understand its implications for the future of clinical research.
-
The Pharmaceutical Industry: 2024 (And Beyond) Predictions
DCTs, RWD, IRA … our industry predictions for 2024 are filled with acronyms. As we delve into 2024, explore what trends are hot ― and not ― for the coming year, and their impact on the industry.
-
Trends In Clinical Trials In 2025: Navigating A Transformative Landscape
In 2025, it is likely the clinical trial landscape will be shaped by advancements in artificial intelligence (AI), evolving recruitment strategies, and a renewed focus on equitable access.
-
FDA Guidance Has Implications For EDC And EHR eSource Capabilities
Gain insight from an eSource study observing digitally received data as far back as 2007 to just before initial guidance was released by the U.S. FDA in 2013.
-
Regulatory Guidance For PRO Strategy In Oncology Trials
Kelly Dumais, Principal Scientific Advisor, and Jowita Marszewska, Scientific Advisor at Clario eCOA, delve into the specifics of how recent regulatory advancements are influencing PRO Strategy.
-
Fujirebio Increases Study Agility By Streamlining Clinical Operations And Data Management Process
Fujirebio’s fast-growing U.S. Clinical R&D team was preparing for shorter studies with higher complexity. Traditional methods using paper and spreadsheet trackers were no longer adequate to meet quality goals. Learn how the group increased its agility and readiness with LifeSphere Clinical EDC and CTMS tools.
-
Patient Caregiver Network Improves Post-Seizure Trial Data
Discover how a pharmaceutical CRO addressed concerns about seizure diary timing in a rare disease study, leveraging insights from Medable's Patient Community Network to optimize data collection.
-
Leveraging The Window Of Opportunity In Clinical Trial Recruitment
Access to real-world data now makes it possible to identify potential trial participants, wherever they are.
- How AI Is Changing Clinical Trial Design, Not Just Speed
- What Is Clinical Trials Day? Why Technology Helps Research Rise
- DiMe's Navigator: Why Teams Still Stall On Digital Endpoints
- Digital Endpoints Are Ready. Clinical Development Isn't
- Why Clinical Trial Data Cleaning Must Go Continuous (And How To Do It)
RECENT NEWSLETTERS
- 05.14.26 -- AI, RWE, And The Systems Breaking Clinical Trials
- 05.07.26 -- How AI, ICH E6(R3) & RWD Are Reshaping Clinical Trials
- 05.02.26 -- Best Of April: AI In Clinical Trials — What Working
- 04.30.26 -- AI, RWE & Predictive Analytics Are Reshaping Trials
- 04.23.26 -- Smarter Trials Start Here: Data Quality, AI & Infrastructure Insights